U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020323

Expand all

VIVELLE (ESTRADIOL)
0.025MG/24HR
Marketing Status: Discontinued
Active Ingredient: ESTRADIOL
Proprietary Name: VIVELLE
Dosage Form; Route of Administration: SYSTEM; TRANSDERMAL
Strength: 0.025MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020323
Product Number: 005
Approval Date: Aug 16, 2000
Applicant Holder Full Name: SANDOZ INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
VIVELLE (ESTRADIOL)
0.0375MG/24HR
Marketing Status: Discontinued
Active Ingredient: ESTRADIOL
Proprietary Name: VIVELLE
Dosage Form; Route of Administration: SYSTEM; TRANSDERMAL
Strength: 0.0375MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020323
Product Number: 001
Approval Date: Oct 28, 1994
Applicant Holder Full Name: SANDOZ INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
VIVELLE (ESTRADIOL)
0.05MG/24HR
Marketing Status: Discontinued
Active Ingredient: ESTRADIOL
Proprietary Name: VIVELLE
Dosage Form; Route of Administration: SYSTEM; TRANSDERMAL
Strength: 0.05MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020323
Product Number: 002
Approval Date: Oct 28, 1994
Applicant Holder Full Name: SANDOZ INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
VIVELLE (ESTRADIOL)
0.075MG/24HR
Marketing Status: Discontinued
Active Ingredient: ESTRADIOL
Proprietary Name: VIVELLE
Dosage Form; Route of Administration: SYSTEM; TRANSDERMAL
Strength: 0.075MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020323
Product Number: 003
Approval Date: Oct 28, 1994
Applicant Holder Full Name: SANDOZ INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
VIVELLE (ESTRADIOL)
0.1MG/24HR
Marketing Status: Discontinued
Active Ingredient: ESTRADIOL
Proprietary Name: VIVELLE
Dosage Form; Route of Administration: SYSTEM; TRANSDERMAL
Strength: 0.1MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020323
Product Number: 004
Approval Date: Oct 28, 1994
Applicant Holder Full Name: SANDOZ INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top